Previous studies indicated that ERβ is a target for CRC prevention due to its activation reduced intestinal tumor formation and represses oncogenes, while its knockout mice exhibited changes in colonic epithelia [10]. The gene discussed is ESR2; the disease is intestinal neoplasm.